Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study DOI Creative Commons
Debendra Nath Roy, Md. Shah Azam, Md. Ekramul Islam

et al.

PLoS ONE, Journal Year: 2023, Volume and Issue: 18(4), P. e0281395 - e0281395

Published: April 13, 2023

Vaccination is the most powerful public health intervention proven to be safe and effective in battle against coronavirus disease-2019 (COVID-19) pandemic. Despite potential therapeutic benefits of primer vaccine dosage regimens, perceptions COVID-19 booster dose (VBD) acceptance hesitancy vary among various sub-group populations. This study investigates compares multi-dimensional factors influencing VBD university teachers student community Bangladesh.

Language: Английский

COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study DOI Creative Commons
Mohamed Lounis, Djihad Bencherit, Mohammed Amir Rais

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(4), P. 621 - 621

Published: April 15, 2022

Due to the emergence of various highly contagious variants SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This has, however, posed another challenge for national authorities convince their population receive booster after first COVID-19 primer dose vaccines. study was conducted determine acceptance and its associated factors general Algeria. Using social media platforms, an online self-administered questionnaire distributed between 28 January 5 March 2022 all Algerian citizens who received Overall, 787 respondents included this study. Among them, 51.6%, 25%, 23.8% accepted, rejected, or hesitant about booster, respectively. However, only 13.2% declared receiving dose. Additionally, while 58.2% being relieved vaccination, 11.4% among them that they regretted vaccinated. The most common reasons experts' recommendations (24.6%) belief necessary efficient, rejection mainly due doses are sufficient (15.5%), vaccination is inefficient (8%). Males, older individuals, those with chronic comorbidities history infection, non-healthcare workers, low educational levels significantly higher odds acceptance. Moreover, disagreeing notion not sufficient, recommendations, desire travel abroad

Language: Английский

Citations

70

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis DOI Creative Commons
Shaimaa Abdelaziz Abdelmoneim, Malik Sallam, Dina Mohamed Hafez

et al.

Tropical Medicine and Infectious Disease, Journal Year: 2022, Volume and Issue: 7(10), P. 298 - 298

Published: Oct. 13, 2022

The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate pooled proportion of COVID-19 vaccine uptake intention get among general populations healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web Science, Google Scholar, ScienceDirect according PRISMA guidelines. From a total 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality Newcastle-Ottawa Scale quality assessment tool. Using included studies, acceptance 198,831 subjects 81% (95% confidence interval (CI): 75–85%, I2 = 100%). actual in eight involving 12,995 31% CI: 19–46%, 100%), while have 79% 72–85%, vaccines HCWs 66% 58–74%), 99%). Meta-regression revealed that previous infection associated with lower dose. Conversely, significantly higher level uptake. WHO region Americas, which did not include any vaccination, 77% 66–85%, Western Pacific 89% 84–92%, 100), followed by European region: 86% 81–90%, 99%), Eastern Mediterranean 59% 46–71%, Southeast Asian 52% 43–61%, 95). Having chronic trust effectiveness significant predictors acceptance. global rate is high, but rates vary region. To achieve herd immunity disease, high required. Intensive campaigns programs are still needed around world raise public awareness regarding importance accepting proper control pandemic.

Language: Английский

Citations

64

Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey DOI Creative Commons
Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(4), P. 515 - 515

Published: March 26, 2022

This was a retrospective cohort study, which aimed to investigate the factors associated with hesitancy receive third dose of coronavirus disease 2019 (COVID-19) vaccine. A paper-based questionnaire survey administered all participants. study included participants who provided answers in about whether they had an intent Data on sex, age, area residence, adverse reactions after second vaccination, vaccination desired, and reasons accept or hesitate over booster were retrieved. Among 2439 participants, mean (±SD) age 52.6 ± 18.9 years, median IgG-S antibody titer 324.9 (AU/mL), 97.9% indicated their dose. The logistic regression revealed that younger (OR = 0.98; 95% CI: 0.96-1.00) higher level 2.52; 1.27-4.99) positively efficacy COVID-19 vaccine concerns significant impact behavior regarding vaccination. rapid increase rate is needed control pandemic, specific approaches should be taken these groups are likely vaccine, subsequently increasing contact rate.

Language: Английский

Citations

62

Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China DOI
Fan Wu, Yue Yuan,

Zhaomin Deng

et al.

Journal of Medical Virology, Journal Year: 2022, Volume and Issue: 94(9), P. 4115 - 4124

Published: May 4, 2022

Abstract The promotion of the booster shots against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is an open issue to be discussed. Little known about public intention and influencing factors regarding vaccine. A cross‐sectional survey in Chinese adults was conducted using online questionnaire, which designed on basis protection motivation theory (PMT) scale vaccine hesitancy (VHS). Hierarchical multiple regression used compare fitness PMT VHS for predicting vaccination intention. Multivariable logistic analyze associated with acceptance. Six thousand three hundred twenty‐one (76.8%) participants were willing take shot. However, rest (23.2%) still hesitant more powerful than explaining Participants high perceived severity (adjusted odds ratio [aOR] = 0.69) response cost (aOR 0.47) less shots, but susceptibility 1.19), efficacy 2.13), self‐efficacy 3.33) shots. In summary, interventions based can provide guidance ensure acceptance

Language: Английский

Citations

58

Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5–11 Years with Chronic Conditions in Italy DOI Creative Commons
Grazia Miraglia del Giudice, Annalisa Napoli, Francesco Corea

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(3), P. 396 - 396

Published: March 4, 2022

COVID-19 vaccination has been extended to include children aged 5-11 years. This cross-sectional survey evaluated parental vaccine willingness and hesitancy, associated factors, for their years with chronic conditions. A telephone was conducted from 14 December 2021 4 January 2022. The questionnaire assessed participants' socio-demographic health-related information, attitudes towards infection, by using the PACV-5 (Parent Attitudes About Childhood Vaccines Survey Tool), sources of information. total 430 answers were collected anonymously. Respondents no cohabitant who had infected SARS-CoV-2 having vaccinated against a higher concern about severity COVID-19. parents' perceived risk that child could be in those more concerned COVID-19, an older child, at least one positive Only 38.8% parents willing vaccinate Parents did not need additional education, have whose older, received information on this physicians, self-reported SARS-CoV-2, expressed greater child. Overall, 26.3% high-hesitant, score ≥ 7. get vaccine, less educated, lower likely high-hesitant. New policies educational programs regarding conditions are needed reduce hesitancy increase uptake.

Language: Английский

Citations

56

Trust in Science as a Possible Mediator between Different Antecedents and COVID-19 Booster Vaccination Intention: An Integration of Health Belief Model (HBM) and Theory of Planned Behavior (TPB) DOI Creative Commons
Massimiliano Barattucci, Stefano Pagliaro, Chiara Ballone

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(7), P. 1099 - 1099

Published: July 8, 2022

As the literature highlights, many health behavior theories try to explain both social and psychological variables influencing an individual's behavior. This study integrates insights relative antecedents of getting vaccinated from theories, particularly including belief model (HBM), theory planned (TPB), different socio-demographic factors. Furthermore, we considered possible mechanism impact distrust in science on individuals' hesitance resistance taking up SARS-CoV-2 vaccination subjects living Italy. A correlational 1095 enrolled when national campaign for third dose was launched. questionnaire used measure: Italian Risk Perception; subjective norm; trust science, vaccine; fear COVID-19; perceived knowledge about SARS-CoV-2; booster intention. Principal results show that: (i) positive relationship provided by HBM between perceptions risk (vulnerability severity) intention have vaccine, through (ii) norms intention; (iii) that plays a crucial role predicting Finally, indications COVID-19, full mediation relationships determinants TPA HBM, In conclusion, (not) get requires consideration plethora socio-psychological However, overall, appears be key determinant Additional strategies promoting healthy are needed.

Language: Английский

Citations

49

Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India DOI Creative Commons
Geetanjali C. Achrekar, Kavita Batra,

Yashashri Urankar

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(7), P. 1048 - 1048

Published: June 30, 2022

The emergence of SARS-CoV-2 mutants, waning immunity, and breakthrough infections prompted the use booster doses COVID-19 vaccine to fight against pandemic. India started in January 2022 it is critical determine intention dose uptake its correlates. Therefore, current cross-sectional study aimed investigate acceptability associated predictors among Indian population. A convenience sampling technique was utilized recruit a sample 687 residents. 55-item psychometric validated survey tool used assess acceptability, literacy confidence. Univariate, bivariate, multivariate statistical methods were analyze data. Over 50% participants reported their willingness take dose. Among group not willing (n = 303, 44.1%), significantly larger proportion respondents unvaccinated with primary series (12.2% vs. 5.2%, p < 0.001), had an annual income below 2.96 lacs/annum (52.8% 33.1, residents rural areas (38.0% 23.2%, living vulnerable individuals (78.5% 65.2%, 0.001) did have family/friends who tested positive for (54.6% 35.1%, 0.001). Demographic, variables multi-theory model subscales predict initiation hesitant statistically significant, R2 0.561, F (26, 244) 11.978, 0.001; adjusted 0.514. Findings this highlight need develop evidence-based interventions promote uptake, particularly hard-to-reach communities developing countries.

Language: Английский

Citations

47

COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study DOI Creative Commons
Arkadiusz Dziedzic, Julien Issa, Salman Hussain

et al.

Frontiers in Public Health, Journal Year: 2022, Volume and Issue: 10

Published: July 25, 2022

Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and vaccination are of vital importance for primary prevention strategies. The present study was designed as cross-sectional survey-based utilizing self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs students medical universities (MUSs). Out the 443 included participants, 76.3% were females, 52.6% HCPs, 31.8% previously infected by SARS-CoV-2, 69.3% had already received doses (VBD). Overall, 74.5% participants willing receive VBD, while 7.9 17.6% exhibited hesitance rejection, respectively. most commonly found promoter acceptance protection one's health (95.2%), followed family's (81.8%) community's (63.3%). Inferential statistics did not show significant association between VBH demographic variables, e.g., age gender; however, who been SARS-CoV-2 significantly more inclined reject VBD. Protection from severe infection, community transmission, good safety profile, favorable risk-benefit ratio determinants VBD uptake. Fear post-vaccination side effects one key barriers accepting which is consistent with pre-existing literature. Public campaigns need highlight postulated benefits vaccines expected harms skipping

Language: Английский

Citations

44

COVID-19 vaccination hesitancy and willingness among pregnant women in Italy DOI Creative Commons
Grazia Miraglia del Giudice, Lucio Folcarelli, Annalisa Napoli

et al.

Frontiers in Public Health, Journal Year: 2022, Volume and Issue: 10

Published: Oct. 3, 2022

Pregnant women, especially those with comorbidities, compared to non-pregnant, have higher risk of developing a severe form COVID-19. However, COVID-19 vaccine uptake is very low among them.An anonymous questionnaire was administered randomly selected women 18 years age that were currently pregnant or had just given birth between September 2021 and May 2022 in the geographic area Naples. Vaccine hesitancy assessed using scale (VHS).A total 385 participated. Women who not been infected by SARS-CoV-2 needed information about vaccination against perceived being SARS-CoV-2. More than half (54.3%) afraid potential side effects on fetus. There concern fetus did graduate degree, high-risk pregnancy, SARS-CoV-2, more concerned they could be know this recommended for them, trusting mass media/internet/social networks information. Only 21.3% vaccinated when pregnant, mostly university before need information, acquired from gynecologists. Almost three-quarters (71.9%) willing receive likely at least one relative/cohabitant partner/friend extremely A 86.4% highly hesitant. Highly hesitant respondents get less information.Public health efforts education campaigns are changing their perception patterns supporting gynecologists promoting vaccination.

Language: Английский

Citations

44

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review DOI Creative Commons
Yam B. Limbu, Bruce A. Huhmann

Tropical Medicine and Infectious Disease, Journal Year: 2023, Volume and Issue: 8(3), P. 159 - 159

Published: March 5, 2023

As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play important role in personal public health. However, convincing people take boosters be a key obstacle. This study systematically analyzed research that examined predictors of vaccine hesitancy. A search PubMed, Medline, CINAHL, Web Science, Scopus uncovered 42 eligible studies. Globally, average vaccination hesitancy rate was 30.72%. Thirteen factors influencing emerged from literature: demographics (gender, age, education, income, occupation, employment status, ethnicity, marital status), geographical influences (country, region, residency), adverse events, perceived benefit/efficacy, susceptibility, severity, prior history infection, recommendations, health knowledge information, skepticism/distrust/conspiracy theories, type. Vaccine communication campaigns interventions for COVID should focus on confidence, complacency, convenience.

Language: Английский

Citations

39